{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:44:28Z","timestamp":1761597868963,"version":"3.37.3"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T00:00:00Z","timestamp":1508803200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T00:00:00Z","timestamp":1508803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000083","name":"Directorate for Computer and Information Science and Engineering","doi-asserted-by":"publisher","award":["IIS-1453658"],"award-info":[{"award-number":["IIS-1453658"]}],"id":[{"id":"10.13039\/100000083","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12859-017-1869-4","type":"journal-article","created":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T14:35:54Z","timestamp":1508855754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["QuaDMutEx: quadratic driver mutation explorer"],"prefix":"10.1186","volume":"18","author":[{"given":"Yahya","family":"Bokhari","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9215-5522","authenticated-orcid":false,"given":"Tomasz","family":"Arodz","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,10,24]]},"reference":[{"issue":"2","key":"1869_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0304-419X(94)90009-4","volume":"1198","author":"P Devilee","year":"1994","unstructured":"Devilee P, Cornelisse CJ. Somatic genetic changes in human breast cancer. Biochim Biophys Acta (BBA)-Rev Cancer. 1994; 1198(2):113\u201330.","journal-title":"Biochim Biophys Acta (BBA)-Rev Cancer"},{"issue":"1","key":"1869_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/ajmg.10320","volume":"111","author":"AG Knudson","year":"2002","unstructured":"Knudson AG. Cancer genetics. Am J Med Genet. 2002; 111(1):96\u2013102.","journal-title":"Am J Med Genet"},{"issue":"6","key":"1869_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0098-2997(00)00007-8","volume":"21","author":"JS Bertram","year":"2000","unstructured":"Bertram JS. The molecular biology of cancer. Mol Asp Med. 2000; 21(6):167\u2013223.","journal-title":"Mol Asp Med"},{"issue":"6127","key":"1869_CR4","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"339","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Kinzler KW. Cancer genome landscapes. Science. 2013; 339(6127):1546\u201358.","journal-title":"Science"},{"issue":"7283","key":"1869_CR5","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/nature08768","volume":"463","author":"GR Bignell","year":"2010","unstructured":"Bignell GR, Greenman CD, Davies H, Butler AP, Edkins S, Andrews JM, Buck G, Chen L, Beare D, Latimer C, et al. Signatures of mutation and selection in the cancer genome. Nature. 2010; 463(7283):893\u20138.","journal-title":"Nature"},{"issue":"D1","key":"1869_CR6","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/nar\/gku1075","volume":"43","author":"SA Forbes","year":"2015","unstructured":"Forbes SA, Beare D, Gunasekaran P, Leung K, Bindal N, Boutselakis H, Ding M, Bamford S, Cole C, Ward S, et al. COSMIC: exploring the world\u2019s knowledge of somatic mutations in human cancer. Nucleic Acid Res. 2015; 43(D1):805\u201311.","journal-title":"Nucleic Acid Res"},{"issue":"D1","key":"1869_CR7","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/nar\/gkv1314","volume":"44","author":"IF Chung","year":"2016","unstructured":"Chung IF, Chen CY, Su SC, Li CY, Wu KJ, Wang HW, Cheng WC. DriverDBv2: a database for human cancer driver gene research. Nucleic Acid Res. 2016; 44(D1):975\u20139.","journal-title":"Nucleic Acid Res"},{"issue":"5","key":"1869_CR8","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jmoldx.2015.05.002","volume":"17","author":"S Damodaran","year":"2015","unstructured":"Damodaran S, Miya J, Kautto E, Zhu E, Samorodnitsky E, Datta J, Reeser JW, Roychowdhury S. Cancer Driver Log (CanDL): catalog of potentially actionable cancer mutations. J Mol Diagn. 2015; 17(5):554\u20139.","journal-title":"J Mol Diagn"},{"issue":"5","key":"1869_CR9","doi-asserted-by":"publisher","first-page":"98293","DOI":"10.1371\/journal.pone.0098293","volume":"9","author":"Y Chen","year":"2014","unstructured":"Chen Y, McGee J, Chen X, Doman TN, Gong X, Zhang Y, Hamm N, Ma X, Higgs RE, Bhagwat SV, et al. Identification of druggable cancer driver genes amplified across TCGA datasets. PLoS One. 2014; 9(5):98293.","journal-title":"PLoS One"},{"issue":"3","key":"1869_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ccell.2015.02.011","volume":"27","author":"E Martinez-Ledesma","year":"2015","unstructured":"Martinez-Ledesma E, de Groot JF, Verhaak RG. Seek and destroy: Relating cancer drivers to therapies. Cancer Cell. 2015; 27(3):319\u201321.","journal-title":"Cancer Cell"},{"key":"1869_CR11","doi-asserted-by":"crossref","unstructured":"Dimitrakopoulos CM, Beerenwinkel N. Computational approaches for the identification of cancer genes and pathways. Wiley Interdiscip Rev Syst Biol Med. 2017;9(1).","DOI":"10.1002\/wsbm.1364"},{"issue":"8","key":"1869_CR12","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nrg3767","volume":"15","author":"L Ding","year":"2014","unstructured":"Ding L, Wendl MC, McMichael JF, Raphael BJ. Expanding the computational toolbox for mining cancer genomes. Nat Rev Genet. 2014; 15(8):556.","journal-title":"Nat Rev Genet"},{"issue":"3","key":"1869_CR13","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/bib\/bbu039","volume":"16","author":"J Chen","year":"2014","unstructured":"Chen J, Sun M, Shen B. Deciphering oncogenic drivers: from single genes to integrated pathways. Brief Bioinform. 2014; 16(3):413\u201328.","journal-title":"Brief Bioinform"},{"issue":"8","key":"1869_CR14","first-page":"16","volume":"200","author":"SC Schuster","year":"2007","unstructured":"Schuster SC. Next-generation sequencing transforms today\u2019s biology. Nature. 2007; 200(8):16\u201318.","journal-title":"Nature"},{"issue":"10","key":"1869_CR15","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"JN Weinstein","year":"2013","unstructured":"Weinstein JN, Collisson EA, Mills GB, Shaw KRM, Ozenberger BA, Ellrott K, Shmulevich I, Sander C, Stuart JM, Network CGAR, et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013; 45(10):1113\u201320.","journal-title":"Nat Genet"},{"issue":"4","key":"1869_CR16","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/genetics\/148.4.1667","volume":"148","author":"JW Drake","year":"1998","unstructured":"Drake JW, Charlesworth B, Charlesworth D, Crow JF. Rates of spontaneous mutation. Genetics. 1998; 148(4):1667\u201386.","journal-title":"Genetics"},{"issue":"6","key":"1869_CR17","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1073\/pnas.1221068110","volume":"110","author":"C Tomasetti","year":"2013","unstructured":"Tomasetti C, Vogelstein B, Parmigiani G. Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation. Proc Natl Acad Sci. 2013; 110(6):1999\u20132004.","journal-title":"Proc Natl Acad Sci"},{"issue":"7412","key":"1869_CR18","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature11273","volume":"488","author":"B Schuster-B\u00f6ckler","year":"2012","unstructured":"Schuster-B\u00f6ckler B, Lehner B. Chromatin organization is a major influence on regional mutation rates in human cancer cells. Nature. 2012; 488(7412):504\u20137.","journal-title":"Nature"},{"issue":"6","key":"1869_CR19","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3109\/03014460.2013.807878","volume":"40","author":"E Bianconi","year":"2013","unstructured":"Bianconi E, Piovesan A, Facchin F, Beraudi A, Casadei R, Frabetti F, Vitale L, Pelleri MC, Tassani S, Piva F, et al. An estimation of the number of cells in the human body. Ann Hum Biol. 2013; 40(6):463\u201371.","journal-title":"Ann Hum Biol"},{"issue":"1","key":"1869_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrm3721","volume":"15","author":"N Barker","year":"2014","unstructured":"Barker N. Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration. Nat Rev Mol Cell Biol. 2014; 15(1):19\u201333.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"1869_CR21","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nrc3063","volume":"11","author":"LA Loeb","year":"2011","unstructured":"Loeb LA. Human cancers express mutator phenotypes: origin, consequences and targeting. Nat Rev Cancer. 2011; 11(6):450\u20137.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"1869_CR22","doi-asserted-by":"publisher","first-page":"1005151","DOI":"10.1371\/journal.pgen.1005151","volume":"11","author":"SR Kennedy","year":"2015","unstructured":"Kennedy SR, Schultz EM, Chappell TM, Kohrn B, Knowels GM, Herr AJ. Volatility of mutator phenotypes at single cell resolution. PLoS Genet. 2015; 11(4):1005151.","journal-title":"PLoS Genet"},{"issue":"7471","key":"1869_CR23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature12634","volume":"502","author":"C Kandoth","year":"2013","unstructured":"Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C, Xie M, Zhang Q, McMichael JF, Wyczalkowski MA, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013; 502(7471):333\u20139.","journal-title":"Nature"},{"issue":"8","key":"1869_CR24","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1073\/pnas.1213968110","volume":"110","author":"CD McFarland","year":"2013","unstructured":"McFarland CD, Korolev KS, Kryukov GV, Sunyaev SR, Mirny LA. Impact of deleterious passenger mutations on cancer progression. Proc Natl Acad Sci. 2013; 110(8):2910\u2013915.","journal-title":"Proc Natl Acad Sci"},{"issue":"7339","key":"1869_CR25","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nature09837","volume":"471","author":"MA Chapman","year":"2011","unstructured":"Chapman MA, Lawrence MS, Keats JJ, Cibulskis K, Sougnez C, Schinzel AC, Harview CL, Brunet JP, Ahmann GJ, Adli M, et al. Initial genome sequencing and analysis of multiple myeloma. Nature. 2011; 471(7339):467\u201372.","journal-title":"Nature"},{"issue":"13","key":"1869_CR26","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1093\/nar\/gkg509","volume":"31","author":"PC Ng","year":"2003","unstructured":"Ng PC, Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003; 31(13):3812\u2013814.","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"1869_CR27","doi-asserted-by":"publisher","first-page":"6660","DOI":"10.1158\/0008-5472.CAN-09-1133","volume":"69","author":"H Carter","year":"2009","unstructured":"Carter H, Chen S, Isik L, Tyekucheva S, Velculescu VE, Kinzler KW, Vogelstein B, Karchin R. Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. Cancer Res. 2009; 69(16):6660\u2013667.","journal-title":"Cancer Res"},{"issue":"4","key":"1869_CR28","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. A method and server for predicting damaging missense mutations. Nat Methods. 2010; 7(4):248\u20139.","journal-title":"Nat Methods"},{"issue":"17","key":"1869_CR29","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1093\/nar\/gkr407","volume":"39","author":"B Reva","year":"2011","unstructured":"Reva B, Antipin Y, Sander C. Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res. 2011; 39(17):e118.","journal-title":"Nucleic Acids Res"},{"issue":"7457","key":"1869_CR30","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, Carter SL, Stewart C, Mermel CH, Roberts SA, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013; 499(7457):214\u20138.","journal-title":"Nature"},{"issue":"12","key":"1869_CR31","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1093\/bioinformatics\/btr193","volume":"27","author":"MC Wendl","year":"2011","unstructured":"Wendl MC, Wallis JW, Lin L, Kandoth C, Mardis ER, Wilson RK, Ding L. PathScan: a tool for discerning mutational significance in groups of putative cancer genes. Bioinformatics. 2011; 27(12):1595\u2013602.","journal-title":"Bioinformatics"},{"issue":"8","key":"1869_CR32","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1101\/gr.134635.111","volume":"22","author":"ND Dees","year":"2012","unstructured":"Dees ND, Zhang Q, Kandoth C, Wendl MC, Schierding W, Koboldt DC, Mooney TB, Callaway MB, Dooling D, Mardis ER, et al. MuSiC: identifying mutational significance in cancer genomes. Genome Res. 2012; 22(8):1589\u201398.","journal-title":"Genome Res"},{"issue":"3","key":"1869_CR33","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.ajhg.2013.07.003","volume":"93","author":"X Hua","year":"2013","unstructured":"Hua X, Xu H, Yang Y, Zhu J, Liu P, Lu Y. DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies. Am J Hum Genet. 2013; 93(3):439\u201351.","journal-title":"Am J Hum Genet"},{"issue":"6","key":"1869_CR34","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/gm563","volume":"6","author":"GE Melloni","year":"2014","unstructured":"Melloni GE, Ogier AG, de Pretis S, Mazzarella L, Pelizzola M, Pelicci PG, Riva L. DOTS-Finder: a comprehensive tool for assessing driver genes in cancer genomes. Genome Med. 2014; 6(6):44.","journal-title":"Genome Med"},{"key":"1869_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1146\/annurev-pathol-012414-040312","volume":"10","author":"JR Pon","year":"2015","unstructured":"Pon JR, Marra MA. Driver and passenger mutations in cancer. Annu Rev Pathol Mech Dis. 2015; 10:25\u201350.","journal-title":"Annu Rev Pathol Mech Dis"},{"issue":"5897","key":"1869_CR36","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1126\/science.1164368","volume":"321","author":"S Jones","year":"2008","unstructured":"Jones S, Zhang X, Parsons DW, Lin JC-H, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, Hong SM, Fu B, Lin MT, Calhoun ES, Kamiyama M, Walter K, Nikolskaya T, Nikolsky Y, Hartigan J, Smith DR, Hidalgo M, Leach SD, Klein AP, Jaffee EM, Goggins M, Maitra A, Iacobuzio-Donahue C, Eshleman JR, Kern SE, Hruban RH, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science. 2008; 321(5897):1801\u201306.","journal-title":"Science"},{"issue":"3","key":"1869_CR37","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1089\/cmb.2010.0265","volume":"18","author":"F Vandin","year":"2011","unstructured":"Vandin F, Upfal E, Raphael BJ. Algorithms for detecting significantly mutated pathways in cancer. J Comput Biol. 2011; 18(3):507\u201322.","journal-title":"J Comput Biol"},{"issue":"2","key":"1869_CR38","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng.3168","volume":"47","author":"MD Leiserson","year":"2015","unstructured":"Leiserson MD, Vandin F, Wu HT, Dobson JR, Eldridge JV, Thomas JL, Papoutsaki A, Kim Y, Niu B, McLellan M, et al. Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes. Nat Genet. 2015; 47(2):106\u201314.","journal-title":"Nat Genet"},{"issue":"2","key":"1869_CR39","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1101\/gr.125567.111","volume":"22","author":"G Ciriello","year":"2012","unstructured":"Ciriello G, Cerami E, Sander C, Schultz N. Mutual exclusivity analysis identifies oncogenic network modules. Genome Res. 2012; 22(2):398\u2013406.","journal-title":"Genome Res"},{"issue":"12","key":"1869_CR40","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/gb-2012-13-12-r124","volume":"13","author":"A Bashashati","year":"2012","unstructured":"Bashashati A, Haffari G, Ding J, Ha G, Lui K, Rosner J, Huntsman DG, Caldas C, Aparicio SA, Shah SP. DriverNet: uncovering the impact of somatic driver mutations on transcriptional networks in cancer. Genome Biol. 2012; 13(12):124.","journal-title":"Genome Biol"},{"issue":"12","key":"1869_CR41","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0968-0004(99)01480-2","volume":"24","author":"F McCormick","year":"1999","unstructured":"McCormick F. Signalling networks that cause cancer. Trends Biochem Sci. 1999; 24(12):53\u20136.","journal-title":"Trends Biochem Sci"},{"issue":"8","key":"1869_CR42","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nm1087","volume":"10","author":"B Vogelstein","year":"2004","unstructured":"Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med. 2004; 10(8):789\u201399.","journal-title":"Nat Med"},{"issue":"8","key":"1869_CR43","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1096\/fj.08-108985","volume":"22","author":"CH Yeang","year":"2008","unstructured":"Yeang CH, McCormick F, Levine A. Combinatorial patterns of somatic gene mutations in cancer. FASEB J. 2008; 22(8):2605\u2013622.","journal-title":"FASEB J"},{"issue":"2","key":"1869_CR44","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1101\/gr.120477.111","volume":"22","author":"F Vandin","year":"2012","unstructured":"Vandin F, Upfal E, Raphael BJ. De novo discovery of mutated driver pathways in cancer. Genome Res. 2012; 22(2):375\u201385.","journal-title":"Genome Res"},{"issue":"5","key":"1869_CR45","doi-asserted-by":"publisher","first-page":"1003054","DOI":"10.1371\/journal.pcbi.1003054","volume":"9","author":"MD Leiserson","year":"2013","unstructured":"Leiserson MD, Blokh D, Sharan R, Raphael BJ. Simultaneous identification of multiple driver pathways in cancer. PLoS Comput Biol. 2013; 9(5):1003054.","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"1869_CR46","first-page":"1","volume":"4","author":"CA Miller","year":"2011","unstructured":"Miller CA, Settle SH, Sulman EP, Aldape KD, Milosavljevic A. Discovering functional modules by identifying recurrent and mutually exclusive mutational patterns in tumors. BMC Med Genet. 2011; 4(1):1.","journal-title":"BMC Med Genet"},{"issue":"1","key":"1869_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-015-0700-7","volume":"16","author":"MD Leiserson","year":"2015","unstructured":"Leiserson MD, Wu HT, Vandin F, Raphael BJ. CoMEt: a statistical approach to identify combinations of mutually exclusive alterations in cancer. Genome Biol. 2015; 16(1):1.","journal-title":"Genome Biol"},{"issue":"7","key":"1869_CR48","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1093\/bioinformatics\/btv400","volume":"32","author":"S Constantinescu","year":"2015","unstructured":"Constantinescu S, Szczurek E, Mohammadi P, Rahnenf\u00fchrer J, Beerenwinkel N. TiMEx: a waiting time model for mutually exclusive cancer alterations. Bioinformatics. 2015; 32(7):968\u201375.","journal-title":"Bioinformatics"},{"issue":"3","key":"1869_CR49","doi-asserted-by":"publisher","first-page":"1003503","DOI":"10.1371\/journal.pcbi.1003503","volume":"10","author":"E Szczurek","year":"2014","unstructured":"Szczurek E, Beerenwinkel N. Modeling mutual exclusivity of cancer mutations. PLoS Comput Biol. 2014; 10(3):1003503.","journal-title":"PLoS Comput Biol"},{"issue":"22","key":"1869_CR50","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1093\/bioinformatics\/bts564","volume":"28","author":"J Zhao","year":"2012","unstructured":"Zhao J, Zhang S, Wu LY, Zhang XS. Efficient methods for identifying mutated driver pathways in cancer. Bioinformatics. 2012; 28(22):2940\u2013947.","journal-title":"Bioinformatics"},{"issue":"1","key":"1869_CR51","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s10878-014-9734-0","volume":"28","author":"G Kochenberger","year":"2014","unstructured":"Kochenberger G, Hao JK, Glover F, Lewis M, L\u00fc Z, Wang H, Wang Y. The unconstrained binary quadratic programming problem: a survey. J Comb Optim. 2014; 28(1):58\u201381.","journal-title":"J Comb Optim"},{"issue":"1","key":"1869_CR52","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.canlet.2013.08.030","volume":"342","author":"B Zhao","year":"2014","unstructured":"Zhao B, Han H, Chen J, Zhang Z, Li S, Fang F, Zheng Q, Ma Y, Zhang J, Wu N, et al. MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3. Cancer Lett. 2014; 342(1):43\u201351.","journal-title":"Cancer Lett"},{"issue":"10","key":"1869_CR53","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1074\/mcp.M110.005397","volume":"10","author":"Y Lei","year":"2011","unstructured":"Lei Y, Huang K, Gao C, Lau QC, Pan H, Xie K, Li J, Liu R, Zhang T, Xie N, et al. Proteomics identification of ITGB3 as a key regulator in reactive oxygen species-induced migration and invasion of colorectal cancer cells. Mol Cell Proteomics. 2011; 10(10):110\u2013005397.","journal-title":"Mol Cell Proteomics"},{"issue":"3","key":"1869_CR54","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ygyno.2015.10.008","volume":"139","author":"X Chen","year":"2015","unstructured":"Chen X, Dong C, Law PT, Chan MT, Su Z, Wang S, Wu WK, Xu H. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer. Gynecol Oncol. 2015; 139(3):513\u20139.","journal-title":"Gynecol Oncol"},{"issue":"33","key":"1869_CR55","doi-asserted-by":"publisher","first-page":"12016","DOI":"10.1073\/pnas.0802261105","volume":"105","author":"M Balastik","year":"2008","unstructured":"Balastik M, Ferraguti F, Pires-da Silva A, Lee TH, Alvarez-Bolado G, Lu KP, Gruss P. Deficiency in ubiquitin ligase TRIM2 causes accumulation of neurofilament light chain and neurodegeneration. Proc Natl Acad Sci. 2008; 105(33):12016\u201321.","journal-title":"Proc Natl Acad Sci"},{"issue":"19","key":"1869_CR56","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.4161\/cc.26062","volume":"12","author":"K Do","year":"2013","unstructured":"Do K, Doroshow JH, Kummar S. Wee1 kinase as a target for cancer therapy. Cell Cycle. 2013; 12(19):3348\u2013353.","journal-title":"Cell Cycle"},{"issue":"3","key":"1869_CR57","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.cell.2006.11.052","volume":"128","author":"A Bagchi","year":"2007","unstructured":"Bagchi A, Papazoglu C, Wu Y, Capurso D, Brodt M, Francis D, Bredel M, Vogel H, Mills AA. CHD5 is a tumor suppressor at human 1p36. Cell. 2007; 128(3):459\u201375.","journal-title":"Cell"},{"issue":"17","key":"1869_CR58","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1038\/sj.onc.1206336","volume":"22","author":"A Beghini","year":"2003","unstructured":"Beghini A, Magnani I, Roversi G, Piepoli T, Di Terlizzi S, Moroni RF, Pollo B, Conti AMF, Cowell JK, Finocchiaro G, et al. The neural progenitor-restricted isoform of the MARK4 gene in 19q13.2 is upregulated in human gliomas and overexpressed in a subset of glioblastoma cell lines. Oncogene. 2003; 22(17):2581\u2013591.","journal-title":"Oncogene"},{"issue":"7","key":"1869_CR59","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s10709-010-9438-z","volume":"138","author":"RS Holmes","year":"2010","unstructured":"Holmes RS, Cox LA, VandeBerg JL. Mammalian carboxylesterase 3: comparative genomics and proteomics. Genetica. 2010; 138(7):695\u2013708.","journal-title":"Genetica"},{"issue":"2","key":"1869_CR60","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cub.2006.11.033","volume":"17","author":"V Clement","year":"2007","unstructured":"Clement V, Sanchez P, De Tribolet N, Radovanovic I, i Altaba AR. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol. 2007; 17(2):165\u201372.","journal-title":"Curr Biol"},{"issue":"22","key":"1869_CR61","doi-asserted-by":"publisher","first-page":"7061","DOI":"10.1158\/0008-5472.CAN-11-1338","volume":"71","author":"YA Yoo","year":"2011","unstructured":"Yoo YA, Kang MH, Lee HJ, Kim B-h, Park JK, Kim HK, Kim JS, Oh SC. Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer. Cancer Res. 2011; 71(22):7061\u2013070.","journal-title":"Cancer Res"},{"issue":"10","key":"1869_CR62","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.cellsig.2009.02.023","volume":"21","author":"M Johnson","year":"2009","unstructured":"Johnson M, Sharma M, Henderson BR. IQGAP1 regulation and roles in cancer. Cell Signal. 2009; 21(10):1471\u201378.","journal-title":"Cell Signal"},{"issue":"2","key":"1869_CR63","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3892\/mco.2014.477","volume":"3","author":"PO de Lima","year":"2015","unstructured":"de Lima PO, dos Santos FV, Oliveira DT, Carvalho de Figueiredo R, Pereira MC. Effect of eosinophil cationic protein on human oral squamous carcinoma cell viability. Mol Clin Oncol. 2015; 3(2):353\u20136.","journal-title":"Mol Clin Oncol"},{"issue":"5","key":"1869_CR64","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1074\/jbc.M112.384289","volume":"288","author":"T Liu","year":"2013","unstructured":"Liu T, Li Y, Gu H, Zhu G, Li J, Cao L, Li F. p21-Activated kinase 6 (PAK6) inhibits prostate cancer growth via phosphorylation of androgen receptor and tumorigenic E3 ligase murine double minute-2 (Mdm2). J Biol Chem. 2013; 288(5):3359\u2013369.","journal-title":"J Biol Chem"},{"issue":"10","key":"1869_CR65","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/jhg.2015.75","volume":"60","author":"K Tomoshige","year":"2015","unstructured":"Tomoshige K, Matsumoto K, Tsuchiya T, Oikawa M, Miyazaki T, Yamasaki N, Mishima H, Kinoshita A, Kubo T, Fukushima K, et al. Germline mutations causing familial lung cancer. J Hum Genet. 2015; 60(10):597\u2013603.","journal-title":"J Hum Genet"},{"issue":"3","key":"1869_CR66","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrc2809","volume":"10","author":"D Wang","year":"2010","unstructured":"Wang D, DuBois RN. Eicosanoids and cancer. Nat Rev Cancer. 2010; 10(3):181\u201393.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"1869_CR67","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/sj.onc.1209827","volume":"26","author":"PA Bignone","year":"2007","unstructured":"Bignone PA, Lee K, Liu Y, Emilion G, Finch J, Soosay A, Charnock F, Beck S, Dunham I, Mungall A, et al. RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer. Oncogene. 2007; 26(5):683\u2013700.","journal-title":"Oncogene"},{"issue":"4","key":"1869_CR68","first-page":"1097","volume":"60","author":"JM Lionberger","year":"2000","unstructured":"Lionberger JM, Smithgall TE. The c-Fes protein-tyrosine kinase suppresses cytokine-independent outgrowth of myeloid leukemia cells induced by Bcr-Abl. Cancer Res. 2000; 60(4):1097\u2013103.","journal-title":"Cancer Res"},{"issue":"1","key":"1869_CR69","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3324\/haematol.2015.131854","volume":"101","author":"MI Del Principe","year":"2016","unstructured":"Del Principe MI, Dal Bo M, Bittolo T, Buccisano F, Rossi FM, Zucchetto A, Rossi D, Bomben R, Maurillo L, Cefalo M, et al. Clinical significance of BAX\/BCL-2 ratio in chronic lymphocytic leukemia. Haematologica. 2016; 101(1):77\u201385.","journal-title":"Haematologica"},{"issue":"6","key":"1869_CR70","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1200\/JCO.1997.15.6.2456","volume":"15","author":"RM Apolinario","year":"1997","unstructured":"Apolinario RM, van der Valk P, de Jong JS, Deville W, van Ark-Otte J, Dingemans A, van Mourik JC, Postmus PE, Pinedo HM, Giaccone G. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer. J Clin Oncol. 1997; 15(6):2456\u2013466.","journal-title":"J Clin Oncol"},{"issue":"7","key":"1869_CR71","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1093\/carcin\/bgs148","volume":"33","author":"P Liu","year":"2012","unstructured":"Liu P, Morrison C, Wang L, Xiong D, Vedell P, Cui P, Hua X, Ding F, Lu Y, James M, et al. Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing. Carcinogenesis. 2012; 33(7):1270\u201376.","journal-title":"Carcinogenesis"},{"issue":"6","key":"1869_CR72","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1158\/0008-5472.CAN-09-3575","volume":"70","author":"S Koutros","year":"2010","unstructured":"Koutros S, Schumacher FR, Hayes RB, Ma J, Huang WY, Albanes D, Canzian F, Chanock SJ, Crawford ED, Diver WR, et al. Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer. Cancer Res. 2010; 70(6):2389\u2013396.","journal-title":"Cancer Res"},{"issue":"14","key":"1869_CR73","doi-asserted-by":"publisher","first-page":"18371","DOI":"10.18632\/oncotarget.7813","volume":"7","author":"D Palmieri","year":"2016","unstructured":"Palmieri D, Scarpa M, Tessari A, Uka R, Amari F, Lee C, Richmond T, Foray C, Sheetz T, Braddom A, et al. Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cells. Oncotarget. 2016; 7(14):18371.","journal-title":"Oncotarget"},{"issue":"2","key":"1869_CR74","first-page":"787","volume":"123","author":"M Kumazoe","year":"2013","unstructured":"Kumazoe M, Sugihara K, Tsukamoto S, Huang Y, Tsurudome Y, Suzuki T, Suemasu Y, Ueda N, Yamashita S, Kim Y, et al.67-kDa laminin receptor increases cGMP to induce cancer-selective apoptosis. J Clin Investig. 2013; 123(2):787.","journal-title":"J Clin Investig"},{"issue":"12","key":"1869_CR75","doi-asserted-by":"publisher","first-page":"7127","DOI":"10.7314\/APJCP.2013.14.12.7127","volume":"14","author":"SC Zhang","year":"2013","unstructured":"Zhang SC, Jin W, Liu H, Jin MJ, Chen ZX, Ding ZY, Zheng SS, Wang LJ, Yu YX, Chen K. RPSA gene mutants associated with risk of colorectal cancer among the Chinese population. Asian Pac J Cancer Prev. 2013; 14(12):7127\u2013131.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"1869_CR76","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s12885-015-1408-5","volume":"15","author":"V Andries","year":"2015","unstructured":"Andries V, Vandepoele K, Staes K, Berx G, Bogaert P, Isterdael G, Ginneberge D, Parthoens E, Vandenbussche J, Gevaert K, et al. NBPF1, a tumor suppressor candidate in neuroblastoma, exerts growth inhibitory effects by inducing a G1 cell cycle arrest. BMC Cancer. 2015; 15(1):391.","journal-title":"BMC Cancer"},{"key":"1869_CR77","doi-asserted-by":"publisher","first-page":"7889","DOI":"10.1038\/ncomms8889","volume":"6","author":"S Meunier","year":"2015","unstructured":"Meunier S, Shvedunova M, Van Nguyen N, Avila L, Vernos I, Akhtar A. An epigenetic regulator emerges as microtubule minus-end binding and stabilizing factor in mitosis. Nat Commun. 2015; 6:7889.","journal-title":"Nat Commun"},{"issue":"10","key":"1869_CR78","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.leukres.2013.07.018","volume":"37","author":"ZG Li","year":"2013","unstructured":"Li ZG, Jiao Y, Li WJ, Deng GR, Cui L, Gao C, Zhao XX, Wu MY, Jia HT. Hypermethylation of two CpG sites upstream of CASP8AP2 promoter influences gene expression and treatment outcome in childhood acute lymphoblastic leukemia. Leuk Res. 2013; 37(10):1287\u201393.","journal-title":"Leuk Res"},{"issue":"2","key":"1869_CR79","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/15384101.2016.1261765","volume":"16","author":"M Sokolova","year":"2017","unstructured":"Sokolova M, Turunen M, Mortusewicz O, Kivioja T, Herr P, V\u00e4h\u00e4rautio A, Bj\u00f6rklund M, Taipale M, Helleday T, Taipale J. Genome-wide screen of cell-cycle regulators in normal and tumor cells identifies a differential response to nucleosome depletion. Cell Cycle. 2017; 16(2):189\u201399.","journal-title":"Cell Cycle"},{"issue":"2","key":"1869_CR80","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cancergencyto.2010.01.003","volume":"198","author":"Y Li","year":"2010","unstructured":"Li Y, Liang Q, Wen Y, Chen L, Wang L, Liu Y, Luo C, Liang H, Li M, Li Z. Comparative proteomics analysis of human osteosarcomas and benign tumor of bone. Cancer Genet Cytogenet. 2010; 198(2):97\u2013106.","journal-title":"Cancer Genet Cytogenet"},{"issue":"11","key":"1869_CR81","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/j.ejca.2007.04.025","volume":"43","author":"S Maier","year":"2007","unstructured":"Maier S, Nimmrich I, Koenig T, Eppenberger-Castori S, Bohlmann I, Paradiso A, Spyratos F, Thomssen C, Mueller V, N\u00e4hrig J, et al. Dna-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients\u2013technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group. Eur J Cancer. 2007; 43(11):1679\u201386.","journal-title":"Eur J Cancer"},{"issue":"1","key":"1869_CR82","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1186\/s12918-014-0136-9","volume":"8","author":"Q Zhang","year":"2014","unstructured":"Zhang Q, Burdette JE, Wang JP. Integrative network analysis of TCGA data for ovarian cancer. BMC Syst Biol. 2014; 8(1):1338.","journal-title":"BMC Syst Biol"},{"issue":"51","key":"1869_CR83","doi-asserted-by":"publisher","first-page":"15168","DOI":"10.1021\/bi062188q","volume":"45","author":"J Li","year":"2006","unstructured":"Li J, Mahajan A, Tsai MD. Ankyrin repeat: a unique motif mediating protein-protein interactions. Biochemistry. 2006; 45(51):15168\u201378.","journal-title":"Biochemistry"},{"issue":"7","key":"1869_CR84","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1073\/pnas.1508541113","volume":"113","author":"KJ Cheung","year":"2016","unstructured":"Cheung KJ, Padmanaban V, Silvestri V, Schipper K, Cohen JD, Fairchild AN, Gorin MA, Verdone JE, Pienta KJ, Bader JS, et al. Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters. Proc Natl Acad Sci. 2016; 113(7):854\u201363.","journal-title":"Proc Natl Acad Sci"},{"issue":"7","key":"1869_CR85","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1245\/s10434-011-1567-9","volume":"18","author":"D Li","year":"2011","unstructured":"Li D, Peng X, Yan D, Tang H, Huang F, Yang Y, Peng Z. Msi-1 is a predictor of survival and a novel therapeutic target in colon cancer. Ann Surg Oncol. 2011; 18(7):2074\u2013083.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"1869_CR86","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nrc3496","volume":"13","author":"MJ Bywater","year":"2013","unstructured":"Bywater MJ, Pearson RB, McArthur GA, Hannan RD. Dysregulation of the basal RNA polymerase transcription apparatus in cancer. Nat Rev Cancer. 2013; 13(5):299\u2013314.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"1869_CR87","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/gb-2011-12-5-r46","volume":"12","author":"ER Gamazon","year":"2011","unstructured":"Gamazon ER, Huang RS, Dolan ME, Cox NJ. Copy number polymorphisms and anticancer pharmacogenomics. Genome Biol. 2011; 12(5):46.","journal-title":"Genome Biol"},{"issue":"1","key":"1869_CR88","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12943-015-0292-6","volume":"14","author":"RW Park","year":"2015","unstructured":"Park RW, Kim TM, Kasif S, Park PJ. Identification of rare germline copy number variations over-represented in five human cancer types. Mol Cancer. 2015; 14(1):25.","journal-title":"Mol Cancer"},{"issue":"1","key":"1869_CR89","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.gene.2013.08.027","volume":"533","author":"J Huan","year":"2014","unstructured":"Huan J, Wang L, Xing L, Qin X, Feng L, Pan X, Zhu L. Insights into significant pathways and gene interaction networks underlying breast cancer cell line MCF-7 treated with 17 \u03b2-estradiol (E2). Gene. 2014; 533(1):346\u201355.","journal-title":"Gene"},{"issue":"5","key":"1869_CR90","doi-asserted-by":"publisher","first-page":"0178322","DOI":"10.1371\/journal.pone.0178322","volume":"12","author":"Y Mei","year":"2017","unstructured":"Mei Y, Bi WL, Greenwald NF, Agar NY, Beroukhim R, Dunn GP, Dunn IF. Genomic profile of human meningioma cell lines. PloS ONE. 2017; 12(5):0178322.","journal-title":"PloS ONE"},{"issue":"19","key":"1869_CR91","doi-asserted-by":"publisher","first-page":"13233","DOI":"10.1074\/jbc.M800234200","volume":"283","author":"MJ Wainszelbaum","year":"2008","unstructured":"Wainszelbaum MJ, Charron AJ, Kong C, Kirkpatrick DS, Srikanth P, Barbieri MA, Gygi SP, Stahl PD. The hominoid-specific oncogene TBC1D3 activates Ras and modulates epidermal growth factor receptor signaling and trafficking. J Biol Chem. 2008; 283(19):13233\u201342.","journal-title":"J Biol Chem"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-017-1869-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12859-017-1869-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-017-1869-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T05:41:47Z","timestamp":1659678107000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-017-1869-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,24]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1869"],"URL":"https:\/\/doi.org\/10.1186\/s12859-017-1869-4","relation":{},"ISSN":["1471-2105"],"issn-type":[{"type":"electronic","value":"1471-2105"}],"subject":[],"published":{"date-parts":[[2017,10,24]]},"assertion":[{"value":"21 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"458"}}